藤黄酸
硫氧还蛋白还原酶
癌细胞
细胞凋亡
硫氧还蛋白
化学
氧化应激
胞浆
细胞毒性
细胞生物学
活性氧
生物化学
癌症研究
生物
体外
酶
癌症
遗传学
作者
Dongzhu Duan,Baoxin Zhang,Juan Yao,Yaping Liu,Jinyu Sun,Chunpo Ge,Shoujiao Peng,Jianguo Fang
标识
DOI:10.1016/j.freeradbiomed.2013.12.027
摘要
The thioredoxin reductase (TrxR) isoenzymes, TrxR1 in cytosol or nucleus and TrxR2 in mitochondria, are essential mammalian selenocysteine (Sec)-containing flavoenzymes with a unique C-terminal -Gly-Cys-Sec-Gly active site. TrxRs are often overexpressed in a number of human tumors, and the reduction of their expression in malignant cells reverses tumor growth, making the enzymes attractive targets for anticancer drug development. Gambogic acid (GA), a natural product that has been used in traditional Chinese medicine for centuries, demonstrates potent anticancer activity in numerous types of human cancer cells and has entered phase II clinical trials. We discovered that GA may interact with TrxR1 to elicit oxidative stress and eventually induce apoptosis in human hepatocellular carcinoma SMMC-7721 cells. GA primarily targets the Sec residue in the antioxidant enzyme TrxR1 to inhibit its Trx-reduction activity, leading to accumulation of reactive oxygen species and collapse of the intracellular redox balance. Importantly, overexpression of functional TrxR1 in cells attenuates the cytotoxicity of GA, whereas knockdown of TrxR1 sensitizes cells to GA. Targeting of TrxR1 by GA thus discloses a previously unrecognized mechanism underlying the biological action of GA and provides useful information for further development of GA as a potential agent in the treatment of cancer. • Gambogic acid (GA) inhibits thioredoxin reductase (TrxR) in vitro and in 7721 cells. • GA treatment leads to accumulation of ROS and depletion of cellular thiols. • Knockdown of TrxR1 sensitizes cells to GA treatment. • Overexpression of functional TrxR1 alleviates GA cytotoxicity. • GA induces oxidative stress-mediated apoptosis in SMMC-7721 cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI